121 related articles for article (PubMed ID: 37648039)
1. SMAD4 and KCNQ3 alterations are associated with lymph node metastases in oesophageal adenocarcinoma.
Foley K; Shorthouse D; Rahrmann E; Zhuang L; Devonshire G; Gilbertson RJ; ; Fitzgerald RC; Hall BA
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166867. PubMed ID: 37648039
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases.
Benech N; O'Brien JM; Barret M; Jacques J; Rahmi G; Perrod G; Hervieu V; Jaouen A; Charissoux A; Guillaud O; Legros R; Walter T; Saurin JC; Rivory J; Prat F; Lépilliez V; Ponchon T; Pioche M
United European Gastroenterol J; 2021 Apr; 9(3):362-369. PubMed ID: 32903167
[TBL] [Abstract][Full Text] [Related]
3. Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation.
Yatagai N; Saito T; Akazawa Y; Hayashi T; Yanai Y; Tsuyama S; Murakami T; Ueyama H; Watanabe S; Nagahara A; Yao T
Hum Pathol; 2019 Jun; 88():18-26. PubMed ID: 30946932
[TBL] [Abstract][Full Text] [Related]
4. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.
Lv J; Cao XF; Ji L; Zhu B; Wang DD; Tao L; Li SQ
Med Oncol; 2012 Mar; 29(1):151-60. PubMed ID: 21259057
[TBL] [Abstract][Full Text] [Related]
5. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience.
Graham D; Sever N; Magee C; Waddingham W; Banks M; Sweis R; Al-Yousuf H; Mitchison M; Alzoubaidi D; Rodriguez-Justo M; Lovat L; Novelli M; Jansen M; Haidry R
World J Gastroenterol; 2018 Nov; 24(41):4698-4707. PubMed ID: 30416317
[TBL] [Abstract][Full Text] [Related]
6. Prediction of lymph node metastases using pre-treatment PET radiomics of the primary tumour in esophageal adenocarcinoma: an external validation study.
Zhang C; Shi Z; Kalendralis P; Whybra P; Parkinson C; Berbee M; Spezi E; Roberts A; Christian A; Lewis W; Crosby T; Dekker A; Wee L; Foley KG
Br J Radiol; 2021 Feb; 94(1118):20201042. PubMed ID: 33264032
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
[TBL] [Abstract][Full Text] [Related]
8. Impaired transforming growth factor beta signalling in Barrett's carcinogenesis due to frequent SMAD4 inactivation.
Onwuegbusi BA; Aitchison A; Chin SF; Kranjac T; Mills I; Huang Y; Lao-Sirieix P; Caldas C; Fitzgerald RC
Gut; 2006 Jun; 55(6):764-74. PubMed ID: 16368780
[TBL] [Abstract][Full Text] [Related]
9. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction.
de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C
Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629
[TBL] [Abstract][Full Text] [Related]
10. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
[TBL] [Abstract][Full Text] [Related]
11. Lymph node metastases and prognosis in oesophageal carcinoma--a systematic review.
Kayani B; Zacharakis E; Ahmed K; Hanna GB
Eur J Surg Oncol; 2011 Sep; 37(9):747-53. PubMed ID: 21839394
[TBL] [Abstract][Full Text] [Related]
12. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.
Cense HA; van Eijck CH; Tilanus HW
Best Pract Res Clin Gastroenterol; 2006; 20(5):893-906. PubMed ID: 16997168
[TBL] [Abstract][Full Text] [Related]
13. Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective study.
Hagens ERC; Künzli HT; van Rijswijk AS; Meijer SL; Mijnals RCD; Weusten BLAM; Geijsen ED; van Laarhoven HWM; van Berge Henegouwen MI; Gisbertz SS
Surg Endosc; 2020 Oct; 34(10):4347-4357. PubMed ID: 31624944
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic changes in metastatic primary Barrett's adenocarcinoma and related lymph node metastases: comparison with nonmetastatic Barrett's adenocarcinoma.
Walch AK; Zitzelsberger HF; Bink K; Hutzler P; Bruch J; Braselmann H; Aubele MM; Mueller J; Stein H; Siewert JR; Höfler H; Werner M
Mod Pathol; 2000 Jul; 13(7):814-24. PubMed ID: 10912943
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
16. Predicting lymph node metastases with endoscopic resection in cT2N0M0 oesophageal cancer: A systematic review and meta-analysis.
Al-Kaabi A; van der Post RS; Huising J; Rosman C; Nagtegaal ID; Siersema PD
United European Gastroenterol J; 2020 Feb; 8(1):35-43. PubMed ID: 32213055
[TBL] [Abstract][Full Text] [Related]
17. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
[TBL] [Abstract][Full Text] [Related]
18. Clinical stage T1-T2N0M0 oesophageal cancer: accuracy of clinical staging and predictive factors for lymph node metastasis.
Shin S; Kim HK; Choi YS; Kim K; Shim YM
Eur J Cardiothorac Surg; 2014 Aug; 46(2):274-9; discussion 279. PubMed ID: 24634481
[TBL] [Abstract][Full Text] [Related]
19. Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples.
van Nistelrooij AM; van Marion R; Koppert LB; Biermann K; Spaander MC; Tilanus HW; van Lanschot JJ; Wijnhoven BP; Dinjens WN
BMC Res Notes; 2017 Apr; 10(1):144. PubMed ID: 28376920
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
